TransMedia Group to promote IntelliGender’s Gender Prediction Test
BOCA RATON, Fla. TransMedia Group on Monday reported it has been retained by IntelliGender to promote that company’s Gender Prediction Test, a simple-to-use urine test that provides immediate gender results.
“Our publicity will focus on promoting IntelliGender as a fun pre-birth experience for expectant mothers who just can’t wait to know,” stated Allison McCormick, public relations manager at TransMedia. “Their unique product appeals to the millions of women who are so excited to be pregnant and are searching for any possible clues about their future bundle of joy. Rather than having to wait until 20 weeks to find out with an ultrasound, moms-to-be can take the test as early as 10 weeks into their pregnancy.”
IntelliGender uses first morning urine and a proprietary mix of chemicals that react with a combination of hormones to indicate the gender.
“We feel that TransMedia Group is the perfect PR firm to represent our innovative product based on their success in helping to make brands such as Celsius and Rexall Sundown household names,” noted Teresa Garland, co-founder of IntelliGender.
Everlast Sports Nutrition launches ProLine collection
NEW YORK Everlast Sports Nutrition on Thursday announced the launch of its ProLine collection, a sports nutrition line of products for pre- and post-workout.
Developed by a team of industry professionals to include nutritionists, athletes and fitness-enthusiasts, ProLine was created to deliver scientifically validated ingredients in proven cutting-edge sports nutrition products for optimum athletic performance, the company stated.
“We’re proud to offer the first comprehensive line of nutritional supplements worthy of the Everlast name,” stated Everlast Sports Nutrition CEO Peter Brechter. “The ProLine rounds out our portfolio, and now we truly have something for everyone.”
The ProLine assortment includes:
- N.O. Nitro-Plex — formulated to support and enhance maximum vascularity, strength, power and endurance. Suggested retail price is $64.99;
- NitroPlex-6 — Designed to effectively increase blood flow, oxygen support and the delivery of nutrients to skeletal muscle. SRP $59.99;
- HyperPlex protein bars — A triple-layered bar with 30 g of protein, designed to support healthy muscle recovery and energy. Available in three flavors: butternut crunch, chocolate caramel nougat and fudge cookie crunch. SRP $2.99;
- HyperPlex protein powder — A protein powder with a multiblend of 25 g of high protein for improved muscle definition. The poweder contains Plyosyl for enhanced muscle and joint health, and improved elasticity and firmness. SRP $44.99;
- HyperPlex ready to drink shake — A protein drink with 40 g of both slow- and fast-acting proteins for muscle recovery and growth. SRP $3.99; and
- Thermo Triplex — A weight-loss supplement combining an appetite suppressant with thermogenic compounds. SRP $64.99.
J&J CEO announces organizational changes
NEW YORK In an interview with the Wall Street Journal on Wednesday, Johnson & Johnson chairman and CEO William Weldon outlined a number of organizational changes taking place across the company in light of the recent spate of recalled products at McNeil Consumer Healthcare, a J&J company.
First, there is the creation of a corporate oversight group, headed by Ajit Shetty, who will be in charge of operations for the company’s pharmaceuticals, medical device and consumer segments. Shetty will report directly to Weldon.
Each of J&J’s business units will field its own chief quality officer, all of whom will report to Shetty. Managers of J&J’s 120 manufacturing facilities worldwide likewise will report to Shetty.
“The people who use our products are our first priority, and we’ve let them down,” Weldon told the Wall Street Journal, adding that the company has “a lot to do to earn [trust in the company] back.”
Weldon also vowed to regain the confidence of retailers impacted by the McNeil recalls over the course of 2011, once production of those recalled medicines resumes. J&J currently is refitting its Fort Washington, Pa., plant and is planning to invest in the upgrade of other McNeil facilities as well. Production at the Fort Washington plant isn’t expected to resume until the second half of 2011. However, McNeil has parlayed production of the recalled products across other sites, and expected to have supply for those products by first quarter 2011, according to previous reports.